Similarity of antibiotic resistance patterns and molecular typing properties of methicillin-resistant Staphylococcus aureus isolates widely spread in hospitals in New York City and in a hospital in Tokyo, Japan

被引:74
作者
De Sousa, MA
De Lencastre, H
Sanches, IS
Kikuchi, K
Totsuka, K
Tomasz, A
机构
[1] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA
[2] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Unidade Genet Mol, P-2780 Oeiras, Portugal
[3] Univ Nova Lisboa, Fac Ciencias & Tecnol, P-2825 Monte De Caparica, Portugal
[4] Tokyo Womens Med Univ, Dept Infect Dis, Tokyo, Japan
来源
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE | 2000年 / 6卷 / 03期
关键词
D O I
10.1089/mdr.2000.6.253
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
One hundred and forty-three single-patient methicillin-resistant Staphylococcus aureus (MRSA) isolates collected during April-June, 1997, and February, 1998, in a hospital in Tokyo, Japan, were characterized by molecular typing techniques that involved hybridization of ClaI restriction digests with the mecA- and Tn554-specific DNA probes and determination of macrorestriction patterns of SmaI-digested chromosomal DNA by pulsed-field gel electrophoresis (PFGE), A large proportion (76%) of the isolates carried the mecA polymorph I, Tn554 pattern A, and PFGE pattern A (clonal type I:A:A), which was the same as the clonal type of an MRSA widely spread in hospitals in New York City and hospitals in neighboring New Jersey, Connecticut, and Pennsylvania, Also similarly to the New York clone, most of the MRSA isolates from the Japanese hospital were resistant to penicillin, ciprofloxacin, erythromycin, tetracycline, and high concentrations (500 mug/ml) of spectinomycin, but were susceptible to chloramphenicol, sulfamethoxazole-trimethoprim, and rifampin, All of the 143 MRSA isolates had vancomycin MICs less than or equal to2 mgL.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 27 条
  • [1] [Anonymous], 1995, J INFECT CHEMOTHER
  • [2] Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P813
  • [3] Centers for Disease Control and Prevention (CDC), 1997, MMWR MORB MORTAL WKL, V46, P765
  • [4] Testing the efficacy of a molecular surveillance network: Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF) genotypes in six hospitals in the Metropolitan New York City Area
    deLencastre, H
    Severina, EP
    Roberts, RB
    Kreiswirth, BN
    Tomasz, A
    Larone, D
    Rahal, J
    Urban, C
    Montecalvo, M
    VanHorn, K
    Currie, B
    McKitrick, J
    Greene, W
    Spitzer, E
    Hargrave, J
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1996, 2 (03): : 343 - 351
  • [5] DELENCASTRE H, 1994, EUR J CLIN MICROBIOL, V13, P64, DOI 10.1007/BF02026129
  • [6] SPREAD AND MAINTENANCE OF A DOMINANT METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS (MRSA) CLONE DURING AN OUTBREAK OF MRSA DISEASE IN A SPANISH HOSPITAL
    DOMINGUEZ, MA
    DELENCASTRE, H
    LINARES, J
    TOMASZ, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (09) : 2081 - 2087
  • [7] AN OVERVIEW OF NOSOCOMIAL INFECTIONS, INCLUDING THE ROLE OF THE MICROBIOLOGY LABORATORY
    EMORI, TG
    GAYNES, RP
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 428 - 442
  • [8] Favero MS, 1996, AM J INFECT CONTROL, V24, P380
  • [9] Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
    Hiramatsu, K
    Aritaka, N
    Hanaki, H
    Kawasaki, S
    Hosoda, Y
    Hori, S
    Fukuchi, Y
    Kobayashi, I
    [J]. LANCET, 1997, 350 (9092) : 1670 - 1673
  • [10] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
    Hiramatsu, K
    Hanaki, H
    Ino, T
    Yabuta, K
    Oguri, T
    Tenover, FC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 135 - 136